1. Home
  2. LEGN vs XP Comparison

LEGN vs XP Comparison

Compare LEGN & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • XP
  • Stock Information
  • Founded
  • LEGN 2014
  • XP 2001
  • Country
  • LEGN United States
  • XP Cayman Islands
  • Employees
  • LEGN N/A
  • XP N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • XP Investment Bankers/Brokers/Service
  • Sector
  • LEGN Health Care
  • XP Finance
  • Exchange
  • LEGN Nasdaq
  • XP Nasdaq
  • Market Cap
  • LEGN 6.7B
  • XP 9.8B
  • IPO Year
  • LEGN 2020
  • XP 2019
  • Fundamental
  • Price
  • LEGN $33.11
  • XP $18.87
  • Analyst Decision
  • LEGN Strong Buy
  • XP Strong Buy
  • Analyst Count
  • LEGN 12
  • XP 5
  • Target Price
  • LEGN $73.36
  • XP $23.80
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • XP 8.1M
  • Earning Date
  • LEGN 11-11-2025
  • XP 08-18-2025
  • Dividend Yield
  • LEGN N/A
  • XP 7.31%
  • EPS Growth
  • LEGN N/A
  • XP 18.07
  • EPS
  • LEGN N/A
  • XP 1.67
  • Revenue
  • LEGN $796,838,000.00
  • XP $3,085,301,717.00
  • Revenue This Year
  • LEGN $70.75
  • XP $18.06
  • Revenue Next Year
  • LEGN $52.47
  • XP $12.97
  • P/E Ratio
  • LEGN N/A
  • XP $11.29
  • Revenue Growth
  • LEGN 74.75
  • XP 6.65
  • 52 Week Low
  • LEGN $27.34
  • XP $10.82
  • 52 Week High
  • LEGN $52.31
  • XP $20.64
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 36.16
  • XP 61.55
  • Support Level
  • LEGN $33.20
  • XP $18.21
  • Resistance Level
  • LEGN $34.71
  • XP $19.19
  • Average True Range (ATR)
  • LEGN 1.22
  • XP 0.54
  • MACD
  • LEGN -0.09
  • XP 0.17
  • Stochastic Oscillator
  • LEGN 10.96
  • XP 88.52

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About XP XP Inc.

XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.

Share on Social Networks: